序号 |
标题 |
次数 |
作者 |
发布时间 |
16021 |
PCL-PEG-MAL,聚己内酯聚乙二醇马来酰亚胺应用于靶向纳米载体 |
39 |
hyy |
2025-05-21 |
16022 |
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine,载阳离子脂质体DOPE的协同递送系统 |
41 |
YFF |
2025-05-21 |
16023 |
Alkyne-PEG-SH,Propyne-PEG-Thiol,炔基PEG巯基 |
81 |
kx |
2025-05-21 |
16024 |
PCL-PEG-cRGD,靶向纳米颗粒材料一种靶向型高分子纳米材料 |
89 |
hyy |
2025-05-21 |
16025 |
PCL-PEG-COOH,聚已内酯-聚乙二醇-羧酸,PCL2K-PEG2K-COOH |
45 |
hyy |
2025-05-21 |
16026 |
PA/CL Liposomes,PA/CL磷脂酸-心磷脂复合阴离子脂质体 用于神经退行性疾病干预 |
48 |
YFF |
2025-05-21 |
16027 |
diethyl 4-bromobutylphosphonate,63075-66-1常规修饰性PEG |
50 |
HLL |
2025-05-21 |
16028 |
HYNIC-Gly3-duramycin,分子量:2319.6 |
55 |
HLL |
2025-05-21 |
16029 |
N3-PEG-OH,N3-PEG-Hydroxy,N3-PEG2000-OH |
49 |
HLL |
2025-05-21 |
16030 |
马来酰亚胺四聚乙二醇羧酸,Mal-PEG4-acid,518044-41-2 |
45 |
HLL |
2025-05-21 |
16031 |
白色粉末1301738-72-6,TRITRAM,双功能大环配体 |
42 |
HLL |
2025-05-21 |
16032 |
白色固体试剂 TBTA,松柏醇,510758-28-8 |
62 |
HLL |
2025-05-21 |
16033 |
cyclo(Phe-Trp),cyclo-(L)-Trp-(L)-Phe,82597-82-8 |
39 |
HLL |
2025-05-21 |
16034 |
Docetaxel Liposome, 多西他赛脂质体(DTX-LP)的应用场景与临床潜力 |
141 |
YFF |
2025-05-21 |
16035 |
cas:252881-76-8,Biotin PEG3 acid的介绍 |
67 |
zyl |
2025-05-21 |
16036 |
Targeted Cytarabine Liposome, 靶向阿糖胞苷脂质体的技术参数与设计要点 |
64 |
YFF |
2025-05-21 |
16037 |
LA-PEG-SH,硫辛酸PEG巯基,硫辛酸聚乙二醇巯基 |
74 |
kx |
2025-05-21 |
16038 |
cas:1309649-57-7,Biotin PEG4 Azide的化学结构与性质 |
72 |
zyl |
2025-05-21 |
16039 |
PLA-PEG-NH2应用于纳米药物载体等 |
68 |
kx |
2025-05-21 |
16040 |
Biotin PEG4 NHS(CAS:459426-22-3)的结构式 |
66 |
zyl |
2025-05-21 |
16041 |
TPP-PEG-PLGA,姜黄素聚乙二醇-聚乳酸聚乙醇酸共聚物脂质体 |
64 |
YFF |
2025-05-21 |
16042 |
Bromo-PEG4-N3(1951439-37-4)Bromo-PEG4-Azide的介绍 |
52 |
zyl |
2025-05-21 |
16043 |
PCL-OH,端羟基聚己内酯 OH-PCL-OH用于医用聚合物 |
76 |
hyy |
2025-05-21 |
16044 |
Targeted Vincristine-Loaded Nanoliposomes,靶向长春新碱纳米脂质体 |
51 |
YFF |
2025-05-21 |
16045 |
PCL-g-PEI,聚己内酯聚乙烯亚胺理想载体材料 |
56 |
hyy |
2025-05-21 |
16046 |
Topotecan Liposomes,拓扑替康脂质体是一种喜树碱类肿瘤药物 |
54 |
YFF |
2025-05-21 |
16047 |
NH2-PEG-COOH,羧基PEG氨基 |
52 |
kx |
2025-05-21 |
16048 |
PCL-FITC,荧光素标记聚己内酯常用于生物成像 |
49 |
hyy |
2025-05-21 |
16049 |
Zoledronic Acid Liposomes (ZOL-LIPs),唑来膦酸脂质体的骨靶向-长效-低毒特性 |
98 |
YFF |
2025-05-21 |
16050 |
HO-PEG-COOH,羟基PEG羧基,羟基聚乙二醇羧基 |
47 |
kx |
2025-05-21 |
16051 |
cas:2872-65-3,4-Methoxyphenyl 2 3 4 6-Tetra-O-acetyl-β,糖苷类化合物的生物应用 |
49 |
axc |
2025-05-21 |
16052 |
N3-PEG-NH2,Azide(click)-PEG-Amine,叠氮PEG氨基 |
52 |
kx |
2025-05-21 |
16053 |
DOTA-GA anhydride,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-琥珀酸酐的化学特性 |
65 |
axc |
2025-05-21 |
16054 |
DSPE-PEG-FITC,DSPE-PEG-fluorescein,磷脂PEG荧光素 |
63 |
kx |
2025-05-21 |
16055 |
DBCO-PEG4-Me-Tetrazine,二苯并环辛炔-四聚乙二醇-甲基-四嗪的物理性质 |
58 |
axc |
2025-05-21 |
16056 |
PCL-COOH,聚己内酯-羧基 |
52 |
hyy |
2025-05-21 |
16057 |
cas:2353409-55-7,Dde TAMRA Biotin Alkyne的化学结构特点 |
71 |
axc |
2025-05-21 |
16058 |
cas:98924-81-3,Ac4GIcNAz N-乙酰葡糖胺叠氮基在药物递送系统中的构建原理 |
86 |
axc |
2025-05-21 |
16059 |
1393330-38-5,Bromo PEG4 acid |
66 |
zyl |
2025-05-21 |
16060 |
PCL-CHO,PCL-cholesterol,聚己内酯-胆固醇两亲性聚合物衍生物 |
54 |
hyy |
2025-05-21 |
16061 |
Mitoxantrone Hydrochloride Liposome,盐酸米托蒽醌脂质体的“增效减毒”特性 |
220 |
YFF |
2025-05-21 |
16062 |
cas:2353409-81-9,Gly-Gly-Gly-PEG3-TCO在药物递送系统的应用优势 |
52 |
axc |
2025-05-21 |
16063 |
cas:504433-88-9,C-Methyl-Ester-Cyclam的合成及纯化过程 |
59 |
axc |
2025-05-21 |
16064 |
ApoB蛋白修饰阿霉素脂质体,ApoB-Lipo/DOX的核心功能与机制 |
88 |
YFF |
2025-05-21 |
16065 |
cas:60239-18-1,DOTA轮环藤宁四乙酸的结构合成 |
51 |
axc |
2025-05-21 |